Literature DB >> 705228

Hypoxanthine in cerebrospinal fluid in children.

A Meberg, O D Saugstad.   

Abstract

In forty-five children the hypoxanthine concentration in cerebrospinal fluid (CSF) was measured (fifty-two samples). In newborn infants (nineteen patients) the hypoxanthine levels were higher in patients with clinical conditions associated with hypoxia (idiopathic respiratory distress syndrome, asphyxia, apneic attacks) than in patients without clinical hypoxia (P less than 0.01). In hypoxic patients the hypoxanthine concentration varied between 5 and 28 mu mol/l. In children outside the neonatal period the hypoxanthine concentration in CSF varied considerably in different diseases. High levels were registered in meningitis prior to treatment, febrile convulsions and in lymphoblastic leukaemia, probably reflecting tissue hypoxia and an increased tissue catabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 705228     DOI: 10.1080/00365517809108448

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

Review 1.  Clinical biochemistry of the neonatal period: immaturity, hypoxia, and metabolic disease.

Authors:  R A Harkness
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

2.  Introduction to the age-related diagnosis (ARD) index: an age at presentation related index for diagnostic use.

Authors:  R A Harkness; E J Harkness
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Cerebrospinal fluid hypoxanthine and xanthine concentrations as indicators of metabolic damage due to raised intracranial pressure in hydrocephalic children.

Authors:  S D Levin; J K Brown; R A Harkness
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

4.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

5.  Therapeutic criteria in hydrocephalic children.

Authors:  M Castro-Gago; I N Rodriguez; A Rodriguez-Núñez; J P Guitián; S L Rocamonde; S Rodriguez-Segade
Journal:  Childs Nerv Syst       Date:  1989-12       Impact factor: 1.475

6.  The concentrations of xanthine and hypoxanthine in cerebrospinal fluid as therapeutic guides in hydrocephalus.

Authors:  M Castro-Gago; S Lojo; R Del Rio; A Rodriguez; I Novo; S Rodriguez-Segade
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

7.  Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage.

Authors:  H von Holst; A Sollevi
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.